Rein Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Rein Therapeutics, Inc. (RNTX) reported Capital Expenditures Incurred but Not yet Paid of $2.87 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2020-03-30
- Rein Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2018-12-31 was $1.43M.
- Rein Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2018-09-30 was $412.00K.
- Rein Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2018 was $2.87M.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2018-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.84M derived: sum of 2 quarters · filed 2020-03-30 | $2.87M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $412.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.44M 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $1.02M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |